发明名称 |
Triazole compouds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
摘要 |
<p>The invention relates to triazole compounds of the general formula I <CHEM> wherein R<1> is hydrogen or methyl, and R<2> is C3-C4 alkyl or C1-C2 fluoroalkyl, as well as the physiologically tolerated acid addition salts of these compounds. <??>The invention also relates to a pharmaceutical composition that comprises at least one triazole compound of the formula I and/or at least one physiologically tolerated acid addition salt thereof, and further to a method for treating disorders that respond beneficially to dopamine D3 receptor antagonists or dopamine D3 agonists, said method comprising administering an effective amount of at least one triazole compound or physiologically tolerated acid addition salt of the formula I to a subject in need thereof.</p> |
申请公布号 |
EP1484330(A1) |
申请公布日期 |
2004.12.08 |
申请号 |
EP20040013358 |
申请日期 |
2004.06.07 |
申请人 |
ABBOTT GMBH & CO. KG |
发明人 |
HAUPT, ANDREAS;GRANDEL, ROLAND;BRAJE, WILFRIED;GENESTE, HERVE;DRESCHER, KARLA;STARCK, DOROTHEA;TESCHENDORF, HANS-JUERGEN |
分类号 |
A61K31/506;A61P25/00;A61P25/18;C07D403/12;(IPC1-7):C07D403/12 |
主分类号 |
A61K31/506 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|